0001104659-21-134395 Sample Contracts
ContractWarrant Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS. EXCEPT AS SET FORTH IN SECTION 6.3 BELOW, THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED, TRANSFERRED, OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT OR APPLICABLE SECURITIES LAWS.
Standard Contracts
CREDIT AGREEMENT among IBIO CDMO LLC, as Borrower and WOODFOREST NATIONAL BANK, as Lender As of November 1, 2021Credit Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS CREDIT AGREEMENT is entered into as of November, 2021 (the “Closing Date”), between iBio CDMO LLC, a Delaware limited liability company (“Borrower”), and WOODFOREST NATIONAL BANK, a national banking association (the “Lender”).
GUARANTY (iBio, Inc.)Guaranty • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 4th, 2021 Company IndustryTHIS GUARANTY (as amended, restated, supplemented or otherwise modified from time to time, this “Guaranty”) is executed as of November 1, 2021, by IBIO, INC., a Delaware corporation (“Guarantor”), for the benefit of WOODFOREST NATIONAL BANK, a national banking association (“Lender”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is entered into as of November 1, 2021 by and between Bryan Capital Investors LLC, a Texas limited liability company (“Seller”) and iBio, Inc., a Delaware corporation (“Buyer”).
SECURITY AGREEMENTSecurity Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS SECURITY AGREEMENT (this “Agreement”) is executed as of November 1, 2021, by IBIO CDMO LLC, a Delaware limited liability company (“Debtor”), for the benefit of WOODFOREST NATIONAL BANK, a national banking association (“Secured Party”).
ENVIRONMENTAL INDEMNITY AGREEMENTEnvironmental Indemnity Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS ENVIRONMENTAL INDEMNITY AGREEMENT (this “Agreement”), is entered into as of November 1, 2021, by IBIO CDMO LLC, a Delaware limited liability company (“Borrower”), and IBIO, INC., a Delaware corporation (“Guarantor”; together with Borrower, each and collectively, “Indemnitor”), in favor of WOODFOREST NATIONAL BANK, a national banking association (together with its successors and assigns, “Lender”), as a condition to, and to induce Lender pursuant to the Credit Agreement (defined below) to make certain extensions of credit to Borrower, secured or to be secured by, among other things, the Deeds of Trust (defined below).
PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS PURCHASE AND SALE AGREEMENT (this “Agreement”) is made as of November 1, 2021, by and between College Station Investors LLC, a Texas limited liability company (“College Station”) and Bryan Capital Investors LLC, a Texas limited liability company (“Bryan Capital”, and collectively with College Station, the “Seller”), iBio, Inc., a Delaware corporation (“Inc.”), and iBio CDMO LLC, a Delaware limited liability company (“CDMO” or “Subtenant”, and collectively with Inc., “Purchaser”).
TERM NOTETerm Note • November 4th, 2021 • iBio, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 4th, 2021 Company IndustryThis term note has been executed and delivered under, and is subject to the terms of, the Credit Agreement dated as of November 1, 2021 (as amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”), between Borrower, as borrower, and Lender and is the Term Note referred to in the Credit Agreement. Unless defined in this note, or the context requires otherwise, capitalized terms used in this note have the meanings given to such terms in the Credit Agreement. Reference is made to the Credit Agreement for provisions affecting this term note regarding applicable interest rates, principal and interest payment dates, final maturity, voluntary and mandatory prepayments, acceleration of maturity, exercise of rights, payment of attorneys’ fees, court costs and other costs of collection, certain waivers by Borrower and others now or hereafter obligated for payment of any sums due under this term note, and security for the payment of this term note. This te